The use of cooled dialysate temperatures first came about in the early 1980s as a way to curb the incidence of intradialytic hypotension (IDH). IDH was then, and it remains today, the most common complication affect...The use of cooled dialysate temperatures first came about in the early 1980s as a way to curb the incidence of intradialytic hypotension (IDH). IDH was then, and it remains today, the most common complication affecting chronic hemodialysis patients. It decreases quality of life on dialysis and is an independent risk factor for mortality. Cooling dialysate was first employed as a technique to incite peripheral vasoconstriction on dialysis and in turn reduce the incidence of intradialytic hypotension. Although it has become a common practice amongst in-center hemodialysis units, cooled dialysate results in up to 70% of patients feeling cold while on dialysis and some even experience shivering. Over the years, various studies have been performed to evaluate the safety and effcacy of cooled dialysate in comparison to a standard, more thermoneutral dialysate temperature of 37℃. Although these studies are limited by small sample size, they are promising in many aspects. They demonstrated that cooled dialysis is safe and equally efficacious as thermoneutral dialysis. Although patients report feeling cold on dialysis, they also report increased energy and an improvement in their overall health following cooled dialysis. They established that cooling dialysate temperatures improves hemodynamic tolerability during and after hemodialysis, even in patients prone to IDH, and does so without adversely affecting dialysis adequacy. Cooled dialysis also reduces the incidence of IDH and has a protective effect over major organs including the heart and brain. Finally, it is an inexpensive measure that decreases economic burden by reducing necessary nursing intervention for issues that arise on hemodialysis such as IDH. Before cooled dialysate becomes standard of care for patients on chronic hemodialysis, larger studies with longer follow-up periods will need to take place to confrm the encouraging outcomes mentioned here.展开更多
BACKGROUND Research exploring the influence of healthier lifestyle modification(LSM)on the risk of hepatocellular carcinoma(HCC)in patients with chronic hepatitis B(CHB)is limited.AIM To emulate a target trial to dete...BACKGROUND Research exploring the influence of healthier lifestyle modification(LSM)on the risk of hepatocellular carcinoma(HCC)in patients with chronic hepatitis B(CHB)is limited.AIM To emulate a target trial to determine the effect of LSM on HCC incidence and mortality among patients with CHB by large-scale population-based observational data.METHODS Among the patients with CHB enrolled in the Korean National Health Insurance Service between January 1,2009,and December 31,2017,those aged≥20 years who drank alcohol,smoked cigarettes,and were sedentary were analyzed.Exposure included at least one LSM,including alcohol abstinence,smoking cessation,and regular exercise.The primary outcome was HCC development,and the secondary outcome was liver-related mortality.We used 2:1 propensity score matching to account for covariates.RESULTS With 48766 patients in the LSM group and 103560 in the control group,the adjusted hazard ratio(HR)for incident HCC and liver-related mortality was 0.92[95%confidence interval(CI):0.87-0.96]and 0.92(95%CI:0.86-0.99)in the LSM group,respectively,compared with the control group.Among the LSM group,the adjusted HR(95%CI)for incident HCC was 0.84(0.76-0.94),0.87(0.81-0.94),and 1.08(1.00-1.16)for alcohol abstinence,smoking cessation,and regular exercise,respectively.The adjusted HR(95%CI)for liver-related mortality was 0.92(0.80-1.06),0.81(0.72-0.91),and 1.15(1.04-1.27)for alcohol abstinence,smoking cessation,and regular exercise,respectively.CONCLUSION LSM lowered the risk of HCC and mortality in patients with CHB.Thus,active LSM,particularly alcohol abstinence and smoking cessation,should be encouraged in patients with CHB.展开更多
Background: Malignant tumors of the child represent one of the major causes of mortality in children between 1 and 14 years in the West. Young people recovering from childhood cancer may have complications related to...Background: Malignant tumors of the child represent one of the major causes of mortality in children between 1 and 14 years in the West. Young people recovering from childhood cancer may have complications related to the disease itself or treatment. Complications can be somatic, psychic or socio-occupational and familial. The current study aims to know the current status of young children treated in the oncology unit of PHOU (Pediatric Hemato-Oncology Unit), Rabat Children Hospital is exclusively or jointly between 1978 and 2004. Material and methods: It will be a cross-sectional study conducted among childhood cancer survivors treated between 1978 and 2004 at the Pediatric Oncology Unit of Children's Hospital of Rabat. Medical and demographic data will be collected through questionnaires completed by phone or intemet, by the survivor, his parent or his physician. Discussion: To our knowledge, there is no previous study about the fate of Moroccan childhood cancer survivors before our study. Hence, it will be a cross-sectional study to have a quick picture on the situation in Morocco. It would be necessary to establish a follow-up strategy in Morocco.展开更多
Breast cancer appears to be a disease of both the developing and developed worlds. Among Moroccan women, breast cancer represents 34.4% of all cancers seen in women. This study aimed to give an overview of the knowled...Breast cancer appears to be a disease of both the developing and developed worlds. Among Moroccan women, breast cancer represents 34.4% of all cancers seen in women. This study aimed to give an overview of the knowledge, attitudes and perceptions related to breast cancer among Moroccan women. To our knowledge there is no previous study in Morocco to assess Moroccan women awareness of breast cancer. A national Cross-sectional study started in July 2011 based on eligible women for early detection programs in basal health centers from five Moroccan regions. A self-filled questionnaire was used to collect data outside working time. Knowledge was assessed using 24 true-false items. The questions were asked about symptoms and risk factors of breast cancer. A score ranging from 0 to 24 was calculated by weighting each item 1 point. Then the score was dichotomized according to the threshold 12 (50% correct answers). The study included 1,444 women from the regions of Rabat, Casablanca, Marrakech, Fez and Meknes. The average age was 40.6 ~ 10 years, 2 women with a minimum age of 17 years and a 1 with a maximum age of 86 years. At the bivariate analysis using chi-square test we found that Marital Status, Social Security, Education, Origin, Sport, Personal History of Cancer, Medical and Surgical personal History were associated with knowledge score. At the multivariate analysis (Logistic regression), we found that Social Security, Education, Origin, Sport were associated to knowledge score at the final model. This study has important implications for health care providers. The poor knowledge of risk factors and practice of breast screening leads to late stage presentation at diagnosis of breast cancer.展开更多
BACKGROUND Hepatitis B virus(HBV)and hepatitis C virus(HCV)viral load(VL)estimation is essential for the management of both HBV and HCV infections.Due to a longer turnaround time for VL estimation,many patients drop o...BACKGROUND Hepatitis B virus(HBV)and hepatitis C virus(HCV)viral load(VL)estimation is essential for the management of both HBV and HCV infections.Due to a longer turnaround time for VL estimation,many patients drop out from the cascade of care.To achieve the global goals of reducing morbidity and mortality due to HBV/HCV and moving towards their elimination by 2030,molecular diagnostic platforms with faster and random(i.e.single sample)access are needed.AIM To evaluate the performance of the recently launched NeuMoDx 96 random access system with the conventional COBAS^(■)AmpliPrep/COBAS TaqMan system for HBV and HCV VL estimation.METHODS Archived once-thawed plasma samples were retrieved and tested on both platforms.Correlation between the assays was determined by linear regression and Bland-Altman analysis.The study included samples from 186 patients,99 for HBV of which 49 were true infected HBV cases(hepatitis B surface antigen,antihepatitis B core antibody,and HBV DNA-positive)and 87 for HCV assay in which 39 were true positives for HCV infection(anti-HCV and HCV RNA-positive).RESULTS The median VL detected by NeuMoDx for HBV was 2.9(interquartile range[IQR]:2.0-4.3)log_(10)IU/mL and by COBAS it was 3.70(IQR:2.28-4.56)log_(10)IU/mL,with excellent correlation(R2=0.98).In HCV,the median VL detected by NeuMoDx was 4.9(IQR:4.2-5.4)log_(10)IU/mL and by COBAS it was 5.10(IQR:4.07-5.80)log_(10)IU/mL with good correlation(R2=0.96).CONCLUSION The overall concordance between both the systems was 100%for both HBV and HCV VL estimation.Moreover,no genotype-specific bias for HBV/HCV VL quantification was seen in both the systems.Our findings reveal that NeuMoDx HBV and HCV quantitative assays have shown overall good clinical performance and provide faster results with 100%sensitivity and specificity compared to the COBAS AmpliPrep/COBAS TaqMan system.展开更多
Appendicitis bilharzia is a very rare condition and we report 3 cases of this pathology that sense clinical and biological similarities with bacterial appendicitis. The etiological diagnosis was exclusively histopatho...Appendicitis bilharzia is a very rare condition and we report 3 cases of this pathology that sense clinical and biological similarities with bacterial appendicitis. The etiological diagnosis was exclusively histopathological, this allowed to highlight eggs of Schistosome in the appendicular wall in the three patients. The surgical treatment was supplemented by a specific medical treatment based on praziquantel. The surgical suites were simple for 2 patients, complicated by superficial parietal suppuration in a patient.展开更多
AIM: To summarize the empirical research on assessing quality of life (QOL) in patients with gastric carcinoma. METHODS: Literature searches were conducted in MedLine from 1966 to February 2004. RESULTS: Twenty-six st...AIM: To summarize the empirical research on assessing quality of life (QOL) in patients with gastric carcinoma. METHODS: Literature searches were conducted in MedLine from 1966 to February 2004. RESULTS: Twenty-six studies were identified. QOL was used as an outcome measure in virtually all identified studies, such as those examining the effects of gastric cancer and various medical or surgical treatments in the patients. QOL was assessed mainly with generic measures; the social dimensions of QOL were largely neglected. The lack of gastric cancer-specific QOL measures hampers QOL research up to now. The gastric cancer-specific EORTCQLQ-STO22 and the FACT-Ga are important additions to the arsenal of disease-specific QOL measures. In most of the studies, the label QOL is used for questionnaires, which only assess symptoms or performance status, or are physician-reported rather than patient-reported outcomes. CONCLUSION: QOL in patients with gastric cancer deserves more systematic studies, especially as one of the outcome measures in randomized clinical trials. Results of studies that include QOL in patients with gastric cancer should be applied in clinical care, which aims at improving QOL of these patients.展开更多
BACKGROUND: The current study evaluated factors influencing survival in patients diagnosed with human immunodeficiency virus (HIV)-related primary central nervous system lymphoma (PCNSL), with a focus on the effects o...BACKGROUND: The current study evaluated factors influencing survival in patients diagnosed with human immunodeficiency virus (HIV)-related primary central nervous system lymphoma (PCNSL), with a focus on the effects of therapeutic radiotherapy (RT) and highly active antiretroviral therapy (HAART). METHODS: A retrospective chart review of patients with a diagnosis of HIV-related PCNSL at one of five university hospitals between 1987 and 1998 was performed. Clinical details including antiretroviral agent use, brain imaging scan results, RT use, and survival outcomes were recorded. RESULTS: One hundred eleven patients with HIV-related PCNSL were identified. The annual incidence decreased significantly between 1992 and 1995 and between 1996 and 1998 (P=0.04).展开更多
Background: Kidney failure causes anemia and is associated with a very high risk of coronary heart disease(CHD). Mildly to moderately decreased kidney function is far more common and also is associated with an elevate...Background: Kidney failure causes anemia and is associated with a very high risk of coronary heart disease(CHD). Mildly to moderately decreased kidney function is far more common and also is associated with an elevated prevalence of anemia and CHD risk. Recent data suggest an even higher risk of CHD when both conditions are present. Methods: We investigated the association of kidney dysfunction and anemia with CHD events(fatal or nonfatal CHD or coronary revascularization procedures) and CHD and all- cause mortality over 12 years of follow- up in 14 971 adults aged 45 to 64 years in the ARIC Study. Glomerular filtration rate(GFR) was estimated from calibrated serum creatinine using the MDRD Study equation(< 30 mL/min per 1.73 m2 excluded, n=32). Anemia was defined as hemoglobin level<13.5 g/dL in men(648/6746, 9.6% ) and< 12 g/dL in women(1049/8225, 12.8% ). Results: The prevalence of anemia was progressively higher at lower estimated GFR< 75 mL/min per 1.73 m2(both P< .001) for both men and women. A total of 1635(10.9% ) participants had a CHD event, 360(2.4% ) died of CHD, and 1722(11.5% ) died of any cause during follow- up. After adjustment for known risk factors, including diabetes, lipid levels, blood pressure, and use of antihypertensive medication, decreased kidney function was associated with a higher risk of recurrent CHD events and mortality from CHD and all causes. These associations were significantly stronger among participants with anemia. The adjusted relative hazards of all- cause mortality associated with moderately decreased versus normal kidney function(GFR 30- 59 vs ≥ 90 mL/min per 1.73 m2) were 1.7(95% CI 1.3- 2.2) in the absence of anemia and 3.5(95% CI 2.4- 5.1) in the presence of anemia(P interaction=.001) . Conclusions: The combination of moderately decreased kidney function and anemia is associated with an increased risk of CHD events and mortality, emphasizing the need to identify individuals with these conditions and evaluate interventions to treat anemia and slow the progression of chronic kidney disease.展开更多
Context:The prevalence of visual impairment in the US public has not been surveyed nationally in several decades.Objective:To estimate the number of US individuals aged 12 years or older who have impaired distance vis...Context:The prevalence of visual impairment in the US public has not been surveyed nationally in several decades.Objective:To estimate the number of US individuals aged 12 years or older who have impaired distance vision due to uncorrected refractive error.Design,Setting,and Participants:The National Health and Nutrition Examination Survey(NHANES),using a multistage probability sampling design,included a vision evaluation in a mobile examination center.Visual acuity data were obtained from 13 265 of 14 203 participants(93.4%)-who visited the mobile examination center in 1999-2002.Visual impairment was defined as presenting distance visual acuity of 20/50 or worse in the better-seeing eye.Visual impairment due to uncorrected refractive error was defined as(presenting)visual impairment that improved,aided by automated refraction results,to 20/40 or better in the better-seeing eye.Main Outcome Measures:Presenting distance visual acuity(measured with usual corrective lenses,if any)and distance visual acuity after automated refraction.Results:Overall,1190 study participants had visual impairment(weighted prevalence,6.4% ;95% confidence interval CI,6.0%-6.8%),and of these,83.3% could achieve good visual acuity with correction(95% CI,80.9%-85.8%).Extrapolating these findings to the general US population,approximately 14 million individuals aged 12 years or older have visual impairment(defined as distance visual acuity of 20/50 or worse),and of these,more than 11 million individuals could have their vision improved to 20/40 or better with refractive correction.Conclusions:Visual impairment due to uncorrected refractive error is a common condition in the United States.Providing appropriate refractive correction to those individuals whose vision can be improved is an important public health endeavor with implications for safety and quality of life.展开更多
Background/Aims:Risks of hepatocellular carcinoma(HCC) following hepatitis B and/or hepatitis C virus(HBV/HCV) infection are well known,those for other cancers are less well understood.The aim was to quantify the risk...Background/Aims:Risks of hepatocellular carcinoma(HCC) following hepatitis B and/or hepatitis C virus(HBV/HCV) infection are well known,those for other cancers are less well understood.The aim was to quantify the risk of cancers among persons diagnosed with HBV/HCV infections.Methods:The data from a cohort of 39109 HBV,75834 HCV,and 2604 HBV/HCV co-infected persons notified to the State health department,1990-2002,were probabilistically linked to the Cancer Registry and standardised incidence ratios(SIRs) for cancer were calculated.Results:The match rate for any cancer was 2.7%,2.3% and 3.3% for HBV,HCV and HBV/HCV co-infected notifications.SIRs for HCC were 30.6(95% CI 25.7-36.5) ,22.7(95% CI 19.1-26.5) and 30.3(95% CI 13.6-67.5) ,respectively.Increased risk was detected for Burkitt’s lymphoma and HBV(SIR 12.9,95% CI 5.4-30.9) and immunoproliferative malignancies following HCV(SIR 5.6,95% CI 1.8-17.5) .Conclusions:The risk of HCC in the infected cohort was 20-30 times greater than in the uninfected population with SIRs two to three times greater than those for the other HBV/HCV infection associated cancers.The modest though significant risk of immunoproliferative malignancies associated with HCV infection is consistent with recent findings.展开更多
In developed countries, currently, more than 80% of children with cancer survive and they are considered as cured. However, the survivors are at high risk of medical and social late effects. In Morocco, childhood canc...In developed countries, currently, more than 80% of children with cancer survive and they are considered as cured. However, the survivors are at high risk of medical and social late effects. In Morocco, childhood cancer accounts for 3% of all cancers. The purpose of this study was to look for factors related to marital status in Moroccan childhood cancer survivors. This was a cross-sectional study conducted among childhood cancer survivors treated between 1978 and 2004 at the Pediatric Oncology Unit of Children's Hospital of Rabat. Medical and demographic data were collected through questionnaires completed by phone or internet, by the survivor, his parent or his physician. Among 995 patients considered cured; only 195 were found. The decline from the initial diagnosis varies from 10 years to 36 years, with a mean of 16.2 years and a standard deviation of 6.3 years. In our study, we found that 31 survivoi's (22.3%) of adult participants were married. They were aged between 23 and 43 (the mean was 31.8 and the SD was 5.9). Men, aged more than 35 years old and unemployed are less likely to be married. To our knowledge, there is no previous study about the fate of Moroccan childhood cancer survivors before our study. Hence, it was a cross-sectional study to have a quick picture on the situation in Morocco. It would be necessary to establish a follow-up strategy in Morocco.展开更多
Backgrounds: Induction of labor is a common practice. In women with </span><span style="font-family:Verdana;">immature</span><span style="font-family:Verdana;"> cervix, PGE2...Backgrounds: Induction of labor is a common practice. In women with </span><span style="font-family:Verdana;">immature</span><span style="font-family:Verdana;"> cervix, PGE2 is commonly used for pre-induction. We hypothesized that PGE2 1.5</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg may be equally effective to PGE2 3</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg in multiparous women for labor induction. The present effort was an attempt to compare the efficacy and effects of pre-induction cervical ripening with PGE2 3</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg vs</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">.</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> 1.5</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg in multi-parous mothers (2nd and 3rd Pregnancy) at 40 weeks.</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span><span><span><span style="font-family:""><span style="font-family:Verdana;">Methods: A </span><span style="font-family:Verdana;">double</span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">-</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">blind</span></span></span></span><span><span><span><span style="font-family:""><span style="font-family:Verdana;"> randomized controlled trial was carried out at Castle Street Hospital for Women, Colombo, Sri Lanka. Study subjects consisted of women with singleton pregnancy (no cesarean history) admitted for delivery at 40 weeks of their 2</span><sup><span style="font-family:Verdana;">nd</span></sup></span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">or 3rd pregnancy. PGE2 1.5</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg vs</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">.</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> 3</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg PGE2 vaginal tablet </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">were</span></span></span></span><span><span><span><span style="font-family:""><span style="font-family:Verdana;"> used for treatment (n = 173) and control (n = 170) groups, respectively. Cervical ripening and maternal, fetal complications were observed. Unfavorable cervices were induced with the same PGE2 dose </span><span style="font-family:Verdana;">in</span><span style="font-family:Verdana;"> the following day. Results: Study group, compared with the control group, achieved the same rate of favorable cervices in 1st and 2nd cycles (63.5</span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">%</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> vs</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">.</span></span></span></span><span><span><span><span style="font-family:""><span style="font-family:Verdana;"> 64%, respectively). Both groups showed the same rate of cervical dilatation </span><span style="font-family:Verdana;">achievement,</span><span style="font-family:Verdana;"> and admissions to </span><span style="font-family:Verdana;">Special</span><span style="font-family:Verdana;"> Care Baby Unit. Study group showed significantly less maternal complications (4% and 11%, respectively: p = 0.01). Conclusion: PGE2 of 1.5</span></span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg is equally effective in achieving favorable cervices, adequate cervical dilatation with minimum maternal complications compared to the usual 3</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg dose in multiparous low-risk women.展开更多
文摘The use of cooled dialysate temperatures first came about in the early 1980s as a way to curb the incidence of intradialytic hypotension (IDH). IDH was then, and it remains today, the most common complication affecting chronic hemodialysis patients. It decreases quality of life on dialysis and is an independent risk factor for mortality. Cooling dialysate was first employed as a technique to incite peripheral vasoconstriction on dialysis and in turn reduce the incidence of intradialytic hypotension. Although it has become a common practice amongst in-center hemodialysis units, cooled dialysate results in up to 70% of patients feeling cold while on dialysis and some even experience shivering. Over the years, various studies have been performed to evaluate the safety and effcacy of cooled dialysate in comparison to a standard, more thermoneutral dialysate temperature of 37℃. Although these studies are limited by small sample size, they are promising in many aspects. They demonstrated that cooled dialysis is safe and equally efficacious as thermoneutral dialysis. Although patients report feeling cold on dialysis, they also report increased energy and an improvement in their overall health following cooled dialysis. They established that cooling dialysate temperatures improves hemodynamic tolerability during and after hemodialysis, even in patients prone to IDH, and does so without adversely affecting dialysis adequacy. Cooled dialysis also reduces the incidence of IDH and has a protective effect over major organs including the heart and brain. Finally, it is an inexpensive measure that decreases economic burden by reducing necessary nursing intervention for issues that arise on hemodialysis such as IDH. Before cooled dialysate becomes standard of care for patients on chronic hemodialysis, larger studies with longer follow-up periods will need to take place to confrm the encouraging outcomes mentioned here.
文摘BACKGROUND Research exploring the influence of healthier lifestyle modification(LSM)on the risk of hepatocellular carcinoma(HCC)in patients with chronic hepatitis B(CHB)is limited.AIM To emulate a target trial to determine the effect of LSM on HCC incidence and mortality among patients with CHB by large-scale population-based observational data.METHODS Among the patients with CHB enrolled in the Korean National Health Insurance Service between January 1,2009,and December 31,2017,those aged≥20 years who drank alcohol,smoked cigarettes,and were sedentary were analyzed.Exposure included at least one LSM,including alcohol abstinence,smoking cessation,and regular exercise.The primary outcome was HCC development,and the secondary outcome was liver-related mortality.We used 2:1 propensity score matching to account for covariates.RESULTS With 48766 patients in the LSM group and 103560 in the control group,the adjusted hazard ratio(HR)for incident HCC and liver-related mortality was 0.92[95%confidence interval(CI):0.87-0.96]and 0.92(95%CI:0.86-0.99)in the LSM group,respectively,compared with the control group.Among the LSM group,the adjusted HR(95%CI)for incident HCC was 0.84(0.76-0.94),0.87(0.81-0.94),and 1.08(1.00-1.16)for alcohol abstinence,smoking cessation,and regular exercise,respectively.The adjusted HR(95%CI)for liver-related mortality was 0.92(0.80-1.06),0.81(0.72-0.91),and 1.15(1.04-1.27)for alcohol abstinence,smoking cessation,and regular exercise,respectively.CONCLUSION LSM lowered the risk of HCC and mortality in patients with CHB.Thus,active LSM,particularly alcohol abstinence and smoking cessation,should be encouraged in patients with CHB.
文摘Background: Malignant tumors of the child represent one of the major causes of mortality in children between 1 and 14 years in the West. Young people recovering from childhood cancer may have complications related to the disease itself or treatment. Complications can be somatic, psychic or socio-occupational and familial. The current study aims to know the current status of young children treated in the oncology unit of PHOU (Pediatric Hemato-Oncology Unit), Rabat Children Hospital is exclusively or jointly between 1978 and 2004. Material and methods: It will be a cross-sectional study conducted among childhood cancer survivors treated between 1978 and 2004 at the Pediatric Oncology Unit of Children's Hospital of Rabat. Medical and demographic data will be collected through questionnaires completed by phone or intemet, by the survivor, his parent or his physician. Discussion: To our knowledge, there is no previous study about the fate of Moroccan childhood cancer survivors before our study. Hence, it will be a cross-sectional study to have a quick picture on the situation in Morocco. It would be necessary to establish a follow-up strategy in Morocco.
文摘Breast cancer appears to be a disease of both the developing and developed worlds. Among Moroccan women, breast cancer represents 34.4% of all cancers seen in women. This study aimed to give an overview of the knowledge, attitudes and perceptions related to breast cancer among Moroccan women. To our knowledge there is no previous study in Morocco to assess Moroccan women awareness of breast cancer. A national Cross-sectional study started in July 2011 based on eligible women for early detection programs in basal health centers from five Moroccan regions. A self-filled questionnaire was used to collect data outside working time. Knowledge was assessed using 24 true-false items. The questions were asked about symptoms and risk factors of breast cancer. A score ranging from 0 to 24 was calculated by weighting each item 1 point. Then the score was dichotomized according to the threshold 12 (50% correct answers). The study included 1,444 women from the regions of Rabat, Casablanca, Marrakech, Fez and Meknes. The average age was 40.6 ~ 10 years, 2 women with a minimum age of 17 years and a 1 with a maximum age of 86 years. At the bivariate analysis using chi-square test we found that Marital Status, Social Security, Education, Origin, Sport, Personal History of Cancer, Medical and Surgical personal History were associated with knowledge score. At the multivariate analysis (Logistic regression), we found that Social Security, Education, Origin, Sport were associated to knowledge score at the final model. This study has important implications for health care providers. The poor knowledge of risk factors and practice of breast screening leads to late stage presentation at diagnosis of breast cancer.
文摘BACKGROUND Hepatitis B virus(HBV)and hepatitis C virus(HCV)viral load(VL)estimation is essential for the management of both HBV and HCV infections.Due to a longer turnaround time for VL estimation,many patients drop out from the cascade of care.To achieve the global goals of reducing morbidity and mortality due to HBV/HCV and moving towards their elimination by 2030,molecular diagnostic platforms with faster and random(i.e.single sample)access are needed.AIM To evaluate the performance of the recently launched NeuMoDx 96 random access system with the conventional COBAS^(■)AmpliPrep/COBAS TaqMan system for HBV and HCV VL estimation.METHODS Archived once-thawed plasma samples were retrieved and tested on both platforms.Correlation between the assays was determined by linear regression and Bland-Altman analysis.The study included samples from 186 patients,99 for HBV of which 49 were true infected HBV cases(hepatitis B surface antigen,antihepatitis B core antibody,and HBV DNA-positive)and 87 for HCV assay in which 39 were true positives for HCV infection(anti-HCV and HCV RNA-positive).RESULTS The median VL detected by NeuMoDx for HBV was 2.9(interquartile range[IQR]:2.0-4.3)log_(10)IU/mL and by COBAS it was 3.70(IQR:2.28-4.56)log_(10)IU/mL,with excellent correlation(R2=0.98).In HCV,the median VL detected by NeuMoDx was 4.9(IQR:4.2-5.4)log_(10)IU/mL and by COBAS it was 5.10(IQR:4.07-5.80)log_(10)IU/mL with good correlation(R2=0.96).CONCLUSION The overall concordance between both the systems was 100%for both HBV and HCV VL estimation.Moreover,no genotype-specific bias for HBV/HCV VL quantification was seen in both the systems.Our findings reveal that NeuMoDx HBV and HCV quantitative assays have shown overall good clinical performance and provide faster results with 100%sensitivity and specificity compared to the COBAS AmpliPrep/COBAS TaqMan system.
文摘Appendicitis bilharzia is a very rare condition and we report 3 cases of this pathology that sense clinical and biological similarities with bacterial appendicitis. The etiological diagnosis was exclusively histopathological, this allowed to highlight eggs of Schistosome in the appendicular wall in the three patients. The surgical treatment was supplemented by a specific medical treatment based on praziquantel. The surgical suites were simple for 2 patients, complicated by superficial parietal suppuration in a patient.
文摘AIM: To summarize the empirical research on assessing quality of life (QOL) in patients with gastric carcinoma. METHODS: Literature searches were conducted in MedLine from 1966 to February 2004. RESULTS: Twenty-six studies were identified. QOL was used as an outcome measure in virtually all identified studies, such as those examining the effects of gastric cancer and various medical or surgical treatments in the patients. QOL was assessed mainly with generic measures; the social dimensions of QOL were largely neglected. The lack of gastric cancer-specific QOL measures hampers QOL research up to now. The gastric cancer-specific EORTCQLQ-STO22 and the FACT-Ga are important additions to the arsenal of disease-specific QOL measures. In most of the studies, the label QOL is used for questionnaires, which only assess symptoms or performance status, or are physician-reported rather than patient-reported outcomes. CONCLUSION: QOL in patients with gastric cancer deserves more systematic studies, especially as one of the outcome measures in randomized clinical trials. Results of studies that include QOL in patients with gastric cancer should be applied in clinical care, which aims at improving QOL of these patients.
文摘BACKGROUND: The current study evaluated factors influencing survival in patients diagnosed with human immunodeficiency virus (HIV)-related primary central nervous system lymphoma (PCNSL), with a focus on the effects of therapeutic radiotherapy (RT) and highly active antiretroviral therapy (HAART). METHODS: A retrospective chart review of patients with a diagnosis of HIV-related PCNSL at one of five university hospitals between 1987 and 1998 was performed. Clinical details including antiretroviral agent use, brain imaging scan results, RT use, and survival outcomes were recorded. RESULTS: One hundred eleven patients with HIV-related PCNSL were identified. The annual incidence decreased significantly between 1992 and 1995 and between 1996 and 1998 (P=0.04).
文摘Background: Kidney failure causes anemia and is associated with a very high risk of coronary heart disease(CHD). Mildly to moderately decreased kidney function is far more common and also is associated with an elevated prevalence of anemia and CHD risk. Recent data suggest an even higher risk of CHD when both conditions are present. Methods: We investigated the association of kidney dysfunction and anemia with CHD events(fatal or nonfatal CHD or coronary revascularization procedures) and CHD and all- cause mortality over 12 years of follow- up in 14 971 adults aged 45 to 64 years in the ARIC Study. Glomerular filtration rate(GFR) was estimated from calibrated serum creatinine using the MDRD Study equation(< 30 mL/min per 1.73 m2 excluded, n=32). Anemia was defined as hemoglobin level<13.5 g/dL in men(648/6746, 9.6% ) and< 12 g/dL in women(1049/8225, 12.8% ). Results: The prevalence of anemia was progressively higher at lower estimated GFR< 75 mL/min per 1.73 m2(both P< .001) for both men and women. A total of 1635(10.9% ) participants had a CHD event, 360(2.4% ) died of CHD, and 1722(11.5% ) died of any cause during follow- up. After adjustment for known risk factors, including diabetes, lipid levels, blood pressure, and use of antihypertensive medication, decreased kidney function was associated with a higher risk of recurrent CHD events and mortality from CHD and all causes. These associations were significantly stronger among participants with anemia. The adjusted relative hazards of all- cause mortality associated with moderately decreased versus normal kidney function(GFR 30- 59 vs ≥ 90 mL/min per 1.73 m2) were 1.7(95% CI 1.3- 2.2) in the absence of anemia and 3.5(95% CI 2.4- 5.1) in the presence of anemia(P interaction=.001) . Conclusions: The combination of moderately decreased kidney function and anemia is associated with an increased risk of CHD events and mortality, emphasizing the need to identify individuals with these conditions and evaluate interventions to treat anemia and slow the progression of chronic kidney disease.
文摘Context:The prevalence of visual impairment in the US public has not been surveyed nationally in several decades.Objective:To estimate the number of US individuals aged 12 years or older who have impaired distance vision due to uncorrected refractive error.Design,Setting,and Participants:The National Health and Nutrition Examination Survey(NHANES),using a multistage probability sampling design,included a vision evaluation in a mobile examination center.Visual acuity data were obtained from 13 265 of 14 203 participants(93.4%)-who visited the mobile examination center in 1999-2002.Visual impairment was defined as presenting distance visual acuity of 20/50 or worse in the better-seeing eye.Visual impairment due to uncorrected refractive error was defined as(presenting)visual impairment that improved,aided by automated refraction results,to 20/40 or better in the better-seeing eye.Main Outcome Measures:Presenting distance visual acuity(measured with usual corrective lenses,if any)and distance visual acuity after automated refraction.Results:Overall,1190 study participants had visual impairment(weighted prevalence,6.4% ;95% confidence interval CI,6.0%-6.8%),and of these,83.3% could achieve good visual acuity with correction(95% CI,80.9%-85.8%).Extrapolating these findings to the general US population,approximately 14 million individuals aged 12 years or older have visual impairment(defined as distance visual acuity of 20/50 or worse),and of these,more than 11 million individuals could have their vision improved to 20/40 or better with refractive correction.Conclusions:Visual impairment due to uncorrected refractive error is a common condition in the United States.Providing appropriate refractive correction to those individuals whose vision can be improved is an important public health endeavor with implications for safety and quality of life.
文摘Background/Aims:Risks of hepatocellular carcinoma(HCC) following hepatitis B and/or hepatitis C virus(HBV/HCV) infection are well known,those for other cancers are less well understood.The aim was to quantify the risk of cancers among persons diagnosed with HBV/HCV infections.Methods:The data from a cohort of 39109 HBV,75834 HCV,and 2604 HBV/HCV co-infected persons notified to the State health department,1990-2002,were probabilistically linked to the Cancer Registry and standardised incidence ratios(SIRs) for cancer were calculated.Results:The match rate for any cancer was 2.7%,2.3% and 3.3% for HBV,HCV and HBV/HCV co-infected notifications.SIRs for HCC were 30.6(95% CI 25.7-36.5) ,22.7(95% CI 19.1-26.5) and 30.3(95% CI 13.6-67.5) ,respectively.Increased risk was detected for Burkitt’s lymphoma and HBV(SIR 12.9,95% CI 5.4-30.9) and immunoproliferative malignancies following HCV(SIR 5.6,95% CI 1.8-17.5) .Conclusions:The risk of HCC in the infected cohort was 20-30 times greater than in the uninfected population with SIRs two to three times greater than those for the other HBV/HCV infection associated cancers.The modest though significant risk of immunoproliferative malignancies associated with HCV infection is consistent with recent findings.
文摘In developed countries, currently, more than 80% of children with cancer survive and they are considered as cured. However, the survivors are at high risk of medical and social late effects. In Morocco, childhood cancer accounts for 3% of all cancers. The purpose of this study was to look for factors related to marital status in Moroccan childhood cancer survivors. This was a cross-sectional study conducted among childhood cancer survivors treated between 1978 and 2004 at the Pediatric Oncology Unit of Children's Hospital of Rabat. Medical and demographic data were collected through questionnaires completed by phone or internet, by the survivor, his parent or his physician. Among 995 patients considered cured; only 195 were found. The decline from the initial diagnosis varies from 10 years to 36 years, with a mean of 16.2 years and a standard deviation of 6.3 years. In our study, we found that 31 survivoi's (22.3%) of adult participants were married. They were aged between 23 and 43 (the mean was 31.8 and the SD was 5.9). Men, aged more than 35 years old and unemployed are less likely to be married. To our knowledge, there is no previous study about the fate of Moroccan childhood cancer survivors before our study. Hence, it was a cross-sectional study to have a quick picture on the situation in Morocco. It would be necessary to establish a follow-up strategy in Morocco.
文摘Backgrounds: Induction of labor is a common practice. In women with </span><span style="font-family:Verdana;">immature</span><span style="font-family:Verdana;"> cervix, PGE2 is commonly used for pre-induction. We hypothesized that PGE2 1.5</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg may be equally effective to PGE2 3</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg in multiparous women for labor induction. The present effort was an attempt to compare the efficacy and effects of pre-induction cervical ripening with PGE2 3</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg vs</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">.</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> 1.5</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg in multi-parous mothers (2nd and 3rd Pregnancy) at 40 weeks.</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span><span><span><span style="font-family:""><span style="font-family:Verdana;">Methods: A </span><span style="font-family:Verdana;">double</span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">-</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">blind</span></span></span></span><span><span><span><span style="font-family:""><span style="font-family:Verdana;"> randomized controlled trial was carried out at Castle Street Hospital for Women, Colombo, Sri Lanka. Study subjects consisted of women with singleton pregnancy (no cesarean history) admitted for delivery at 40 weeks of their 2</span><sup><span style="font-family:Verdana;">nd</span></sup></span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">or 3rd pregnancy. PGE2 1.5</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg vs</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">.</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> 3</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg PGE2 vaginal tablet </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">were</span></span></span></span><span><span><span><span style="font-family:""><span style="font-family:Verdana;"> used for treatment (n = 173) and control (n = 170) groups, respectively. Cervical ripening and maternal, fetal complications were observed. Unfavorable cervices were induced with the same PGE2 dose </span><span style="font-family:Verdana;">in</span><span style="font-family:Verdana;"> the following day. Results: Study group, compared with the control group, achieved the same rate of favorable cervices in 1st and 2nd cycles (63.5</span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">%</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> vs</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">.</span></span></span></span><span><span><span><span style="font-family:""><span style="font-family:Verdana;"> 64%, respectively). Both groups showed the same rate of cervical dilatation </span><span style="font-family:Verdana;">achievement,</span><span style="font-family:Verdana;"> and admissions to </span><span style="font-family:Verdana;">Special</span><span style="font-family:Verdana;"> Care Baby Unit. Study group showed significantly less maternal complications (4% and 11%, respectively: p = 0.01). Conclusion: PGE2 of 1.5</span></span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg is equally effective in achieving favorable cervices, adequate cervical dilatation with minimum maternal complications compared to the usual 3</span></span></span></span><span><span><span><span style="font-family:""> </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">mg dose in multiparous low-risk women.
基金supported by a grant for a‘Study for effective TB controlincluding a cost-benefitanalysis of periodic health examination and BCG’from the Japanese Ministry of HealthLabour and Welfare(grant no17210601)